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Background: Although Cognitive-Behavioral Therapy (CBT) is effective for Unexplained Physical Symptoms (UPS),
some therapists in clinical practice seem to believe that CBT outcome will diminish if psychiatric comorbidity is
present. The result is that patients with a psychiatric comorbidity are redirected from treatment for UPS into
treatment for mental health problems. To explore whether this selection and allocation are appropriate, we
explored whether CBT outcomes in UPS could be predicted by variables assessed at baseline and used in
routine-practice assessments.
Methods: Patients (n=162) with UPS classified as undifferentiated somatoform disorder or chronic pain disorder
were followed up until one year after they had attended a CBT group training. The time-points of the follow-up
were at the end of CBT (immediate outcome), three months after CBT (short-term outcome), and one year after
CBT (long-term outcome).
CBT outcome was measured using the Physical Component Summary of the SF-36, which was the primary
outcome measure in the randomized controlled trial that studied effectiveness of the CBT group training. Predictors
were: 1.) psychological symptoms (global severity score of SCL-90), 2.) personality-disorder characteristics (sum of
DSM-IV axis II criteria confirmed), 3.) psychiatric history (past presence of DSM-IV axis I disorders), and 4.)
health-related quality of life in the mental domain (mental component summary of SF-36). The effect of this
predictor set was explored using hierarchical multiple regression analyses into which these predictors had been
entered simultaneously, after control for: a.) pretreatment primary outcome scores, b.) age, c.) gender, d.) marital
status, and e.) employment.
Results: The predictor set was significant only for short-term CBT outcome, where it explained 15% of the variance.
A better outcome was predicted by more psychological symptoms, fewer personality-disorder characteristics, the
presence of a psychiatric history, and a better quality of life in the mental domain.
Conclusions: As the predictors do not seem to predict CBT outcome consistently over time, the need for selection
and allocation of patients for CBT is doubtful. It seems that this would unnecessarily deprive patients of effective
treatment.
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Although Cognitive-Behavioral Therapy (CBT) is effect-
ive for Unexplained Physical Symptoms (UPS) [1-6],
some therapists in clinical practice seem to believe that
it is not equally effective for all patients with UPS. In-
stead, they assume that outcome will be poorer in
patients whose quality of life may have been affected by
a psychiatric comorbidity such as depression, anxiety
disorder, personality-disorder, or their psychiatric
history.
Inconsistent findings have been produced by studies
that investigated whether such comorbidity did indeed
predict poor outcome [7-21]. Some studies showed that
poor treatment outcome for UPS was predicted by con-
current depressive symptoms [9], anxiety symptoms
[10], personality-disorder characteristics [11], a psychi-
atric history [12,21] or poor health-related quality of life
[12]. Other studies used the same predictors to conclude
differently. Thus, for concurrent depressive symptoms,
one study found that depressive symptoms predicted a
better outcome [13], while others showed no influence
[7,8,10,11,14-20]. For concurrent anxiety symptoms, an-
other study found that anxiety, too, predicted a better
outcome [14], while others showed no influence
[7,8,11,15-19]. For concurrent personality disorders, two
further studies found that a personality disorder did not
predict outcome – though they also implied that a per-
sonality disorder might increase the drop-out rate [8,16].
For psychiatric history, a further study showed no influ-
ence on outcome [9]. For health-related quality of life,
another study reported that poorer functioning valued
by assessors and a poorer quality of life reported by
patients were associated with better outcome [15]. Con-
clusions on whether psychiatric comorbidity predicted
outcome differed not only between studies, but also
within them [12,15]. For example, one study [12] found
that depressive symptoms did not predict post-treatment
outcome, but did predict better three-month follow-up
outcome.
One possible reason for these inconsistent findings on
predicting CBT outcome in UPS is that the impact of
psychiatric comorbidity was blurred by differences in the
outcome scores at baseline or in socio-demographic
variables at baseline. Various studies showed that the
outcome was influenced by the pretreatment score on
the outcome measure [10,12,15], and by socio-
demographic variables such as age [10,12,14,20], gender
[15], marital status [13], or having paid work [15,17].
To find predictors that consistently predict CBT out-
come over time, we explored whether psychological
symptoms, personality-disorder characteristics, psychi-
atric history, and health-related quality of life in the
mental domain assessed at baseline predicted CBT out-
come on the primary outcome measure at the end ofCBT (immediate outcome), three months after CBT
(short-term outcome), and one year after CBT (long-
term outcome), all after control for pretreatment scores
on the outcome measure and for socio-demographic
variables. In line with clinical practice, that was sup-
ported but also contradicted by a number of studies, we
hypothesized that better CBT outcome would be pre-
dicted by the following: fewer psychological symptoms
and personality-disorder characteristics, the absence of a
psychiatric history, and a better quality of life in the
mental domain.
Methods
Design
The data for this study came from a randomized con-
trolled trial on the effectiveness of cognitive-behavioral
group training (CBT) for patients with UPS [22].
Patients with UPS were randomized either to CBT or to
a waiting list after they had completed the baseline
measurement (T0). The second measurement (T1) was
made directly after the training (13 weeks), or, for those
on the waiting list, after the same period. The mainten-
ance of the effect of the group training was investigated
in a non-randomized one-year follow-up. To this end,
patients who had been randomized to the waiting list
and had waited started the training after their second
measurement (T1). Patients who had attended the train-
ing directly after randomization or after the waiting
period were followed-up three months after the end of
treatment (T2), and again one year later (T3).
The study was approved by the Erasmus Medical Re-
search Ethics Committee, and registered in the Dutch
Trial Register (NTR 1609) [23]. A detailed description of
the protocol has been published earlier in this journal
[24].
Participants
Patients were recruited between February 2005 and Sep-
tember 2008 in general practices, in outpatient clinics at
general hospitals, and by Riagg Rijnmond, a secondary
community mental-health service for the greater Rotter-
dam area in the Netherlands. General practitioners and
specialists were asked to refer patients aged between 18
and 65 years whose physical symptoms, according to
clinical judgment, could not be fully explained on the
basis of a known medical condition. Patients were
included if they signed the informed consent and if their
UPS fulfilled the DSM-IV criteria for an undifferentiated
somatoform disorder or a chronic pain disorder.
We chose UPS classified with DSM-IV as ‘undifferenti-
ated somatoform disorder’ or as ‘chronic pain disorder’,
as these disorders were given clinical relevance by their
high prevalence – in general practices, they are the most
prevalent of all somatoform disorders [25] – and as they
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‘Undifferentiated somatoform disorder’ and ‘chronic pain
disorder’ are non-overlapping disorders because of cri-
terion E in the DSM-IV criteria for ‘undifferentiated
somatoform disorder’, which states that the disorder can
be assigned only if the symptoms are not better
accounted for by another mental disorder such as an-
other somatoform disorder.
To verify whether UPS fulfilled all DSM-IV criteria for
either ‘undifferentiated somatoform disorder’ or ‘chronic
pain disorder’, we used the Structured Clinical Interview
for DSM-IV Axis I Disorders (SCID-I) [26], a semi-
structured validated and reliable interview for making
the major DSM-IV Axis I diagnoses.
Patients were excluded if they did not provide
informed consent, or if poor language skills or handicaps
such as cognitive impairment prevented them from
understanding the CBT group training.
CBT group training
The intervention, a CBT group training called ‘Coping
with the consequences of unexplained physical symp-
toms’, is a weekly two-hour manual-based [27] training
that is held over a 13-week period. It uses the following
CBT techniques: psychoeducation, response prevention,
pacing activity, graded activity, graded exercise, prob-
lem-solving, breathing and relaxation exercise, cognitive
intervention using the Ellis’ ABC worksheet, and relapse
prevention. Its aim is to improve health-related quality
of life. A more detailed description of this CBT has been
published elsewhere [24,28].
CBT outcome measurement
In the randomized controlled trial, the primary outcome
was the summary scales of the 36-item Medical Out-
comes Study Short-Form General Health Survey (SF-36)
[29]: Physical Component Summary’ (PCS) and ‘Mental
Component Summary’ (MCS). In the present study, the
PCS was chosen as outcome measurement, because
patients reported the quality of life in the physical do-
main as most burdensome. The group training signifi-
cantly improved quality of life in the physical domain,
and this positive effect was maintained during the entire
one-year follow-up period [30].
The PCS summarizes functional health and well-being
in the physical domain over the past four weeks. This
summary is transformed into T-scores with a mean of
50 and standard deviation of 10. A higher summary
score indicates a better quality of life. The CBT outcome
score was the difference between the baseline PCS score
and the following: post-treatment PCS scores (immedi-
ate outcome); three-month follow-up PCS scores (short-
term outcome); and one-year follow-up PCS scores
(long-term outcome). A higher CBT outcome scoreindicates more improvement of quality of life in the
physical domain.
Predictors
Psychological symptoms
Psychological symptoms were measured using the
revised 90-item Symptom Checklist (SCL-90-R). This is a
validated and reliable self-report questionnaire with 90
questions and five fixed-response alternatives (Likert-
type format: Not at all; Somewhat; Moderately; Very
much; Absolutely) for evaluating a broad range of psy-
chological symptoms, including anxiety and depression,
over the past week [31]. The responses are summed up
in the ‘Global severity index’. A higher score on this
index indicates more severe psychological symptoms or
a higher number of psychological symptoms.
Personality-disorder characteristics
Personality-disorder characteristics were measured using
the Vragenlijst Kenmerken van Persoonlijkheid (VKP), a
Dutch self-report questionnaire based on the Inter-
national Personality Disorder Examination [32]. The
VKP is a validated and reliable self-report questionnaire
with 197 questions and three fixed-response alternatives
(true; ?; false) for assessing the presence of DSM-IV axis
II criteria of personality disorders over the past five
years. ‘Personality-disorder characteristics’ were calcu-
lated by summing DSM-IV axis II criteria, to which was
responded with “true”. A higher sum score indicates a
higher number of DSM-IV axis II criteria confirmed.
Presence of DSM-IV axis I disorders in the past (‘psychiatric
history’)
The presence per patient of DSM-IV axis I disorders,
both currently and over their lifetime, was measured
using the Structured Clinical Interview for DSM-IV axis
I disorders (SCID-I) [26]. This is a semi-structured vali-
dated interview for classifying the major DSM-IV axis I
disorders. The presence of these disorders in the past
(‘psychiatric history’) was calculated by summing disor-
ders in lifetime that were not currently present, and
splitting the sum score into two categories (no DSM-IV
axis I in the past, 0; or one or more DSM-IV axis I disor-
ders in the past that were not currently present, 1).
Health-related quality of life in the mental domain (‘mental
component summary’)
Health-related quality of life in the mental domain was
measured using the ‘Mental Component Summary’
(MCS) of the SF-36 [29]. The MCS summarizes func-
tional health and well-being in the mental domain over
the past four weeks. This summary is transformed into
T-scores with a mean of 50 and standard deviation of
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quality of life in the mental domain.
Control variables
Pretreatment PCS scores, age, gender, marital status and
employment status were used as control variables.
Statistical analyses
Required sample size
The randomized controlled trial on the effectiveness of
the CBT group training resulted in a group of 162
patients. To verify whether this fixed number of patients
was also sufficient for the present study, we applied a
power analysis to calculate the sample size required for
the present study [33,34].
For this power analysis, the anticipated effect size of
the set predictors was set at f2=0.15 [35]. We decided
that the set should at least have this medium effect, be-
cause the predictors would exclude patients from treat-
ment that had an exceptionally small risk of adverse
events [36], and, also, because the selection and alloca-
tion assessment needed for this exclusion would raise
costs. The desired statistical power level was set at 0.80
and the alpha at 0.05; both by convention [35]. The
number of predictors was four, while the number of con-
trol variables was five. The predictors were selected on
the basis of assumptions practiced in clinical practice.
The control variables were chosen on the basis of find-
ings of other studies that indicated the potential rele-
vance of these variables for CBT outcome. By selecting
predictors used in clinical practice and by choosing con-
trol variables indicated by studies as potentially relevant,
we reduced the number of predictors and control vari-
ables, and prevented ‘fishing’.
A power analysis with these parameters led to a mini-
mum required sample size of 113 patients [37,38].
Adjusted for a dropout of 30 percent, this resulted in a
total sample size of 161. The total sample size of 162 in
the randomized controlled trial was thus sufficient for
the hierarchical multiple regression analyses of the
present study.
Analyses
The statistical analyses concern drop-out and prediction.
Drop-out analyses explored whether the patients who
dropped out differed at baseline from study completers
(patients who could be followed over a year). This was
analyzed using two-tailed t-tests for independent sam-
ples for the continuous variables, two-tailed Mann–
Whitney U-tests for the ordinal variables, and chi-square
tests for the categorical variables.
The prediction analyses included a preliminary explor-
ation of the relationships between the individual predic-
tors and CBT outcomes, and a full exploration of thepredictive power of the predictor set while controlling
for pre-treatment score of the outcome measure and
socio-demographic variables. For the preliminary explor-
ation, a correlation matrix was composed. For the full ex-
ploration, hierarchical multiple regression analyses were
used. In the first step of these regression analyses, pre-
treatment score on the outcome measure and socio-
demographic variables were simultaneously entered as a
block to statistically control for their impact on outcome.
In the second step of these regression analyses, the pre-
dictors were simultaneously entered as a block to evalu-
ate their impact as a set and as individual predictors on
outcome. Since predictors have clinical relevance only if
they are stable over time, these analyses were conducted
for immediate, short-term and long-term CBT outcomes.
Five checks were used to verify whether the assump-
tions of hierarchical multiple regression analysis had
been met and how accurate the resulting model was
[33,39]. The first check used was Cook’s distance to ex-
plore whether the model was highly influenced by a
small number of cases. The second check used was tol-
erance to confirm non-multicollinearity. The third check
used was the Durbin-Watson statistics to confirm the
independency of errors. The fourth check used was re-
sidual plots to explore for linearity and homoscedasti-
city. The fifth check used was the Shapiro-Wilk test to
confirm the normality of standardized residuals.
Results
Patients
Figure 1 shows the flow chart of patients through the
study. The study started with 162 patients, 59 of whom
dropped out.
The 59 patients who had dropped out of the study did
not differ from the study completers with regard to their
available scores for CBT outcome, control variables, and
predictors (see Table 1), with the exception of a differ-
ence in the ‘age’ control variable. Patients who had
dropped out were significantly younger (M=42.4,
SD=11.1, p=.02) than the study completers (M=46.7,
SD=10.8).
With regard to the clinical characteristics shown in
Table 2, no significant differences were found between
the patients who had dropped out and the study
completers.
Correlations between CBT outcomes, control variables,
and predictors
Table 3 shows the correlation matrix between the CBT
outcomes, the control variables, and predictors. With re-
gard to the control variables, the only control variable
that predicted outcome consistently over time was the
pretreatment PCS score. A lower pretreatment PCS
score was associated with a better CBT outcome. The
Figure 1 Patient flow.
Zonneveld et al. BMC Public Health 2012, 12:848 Page 5 of 10
http://www.biomedcentral.com/1471-2458/12/848pretreatment PCS scores explained five to nine per cent
of the variance in CBT outcome. With regard to the pre-
dictors, no predictor predicted outcome consistently
over time. The correlations with CBT outcomes were ra-
ther low according to Cohen’s guidelines [35]. Only the
pretreatment MCS scores were significantly correlated
with CBT short-term outcome. A higher pretreatment
MCS score was associated with a better CBT short-term
outcome. These pretreatment MCS scores explained six
percent of the variance in the short-term CBT outcome.
Prediction of immediate, short-term and long-term
CBT outcome
Table 4 shows the hierarchical multiple regression
models for predicting CBT outcome. The complete modelwas able to predict immediate CBT outcome (F(9, 92)=2.12,
p=.04) and short-term CBT outcome (F(9,95)=2.85, p=.005);
but not long-term CBT outcome (F(9, 88)=1.81, p=.08).
When the effects of pretreatment outcome scores and
socio-demographic variables were statistically controlled, the
predictor set was only able to predict short-term CBT out-
come (F(4,95)=4.41, p=.003); but not immediate CBT out-
come (F(4,92)=0.17, p=.17) and long-term CBT outcome
(F(4,88)=1.54, p=.20). The resulting explained variance in
CBT outcome training was 6% at the end of CBT, 15% at
three-month follow-up, and 6% at one-year follow-up. For
short-term CBT outcome, better outcome was predicted
by more psychological symptoms, fewer personality-disorder
characteristics, the presence of a psychiatric history, and a
better quality of life in the mental domain. There were no
Table 1 Characteristics of CBT outcomes, control
variables, and predictors
CBT outcome n
Immediate CBT outcome, mean (SD) 102 4.49 (7.59)
Short-term CBT outcome, mean (SD) 105 4.68 (6.79)
Long-term CBT outcome, mean (SD) 98 5.03 (7.55)
Control variables n
Physical Component Summary - PCS,
mean (SD)
158 29.20 (8.97)
Age in years, mean (SD) 162 45.15 (11.05)
Gender, n (%) 162
female 131 (81%)
male 31 (19%)
Marital status, n (%) 162
married/living with a partner 110 (68%)
unmarried/divorced/widowed 52 (32%)
Employment, n (%) 162
having employment 57 (35%)
having no employment 105 (65%)
Predictors n
Global severity index, mean (SD) 161 165.36 (50.28)
Personality-disorder characteristics,
mean (SD)
160 15.07 (12.96)
Psychiatric history, n (%) 162
presence of a psychiatric history 68 (42%)
absence of a psychiatric history 94 (58%)
Mental Component Summary - MCS,
mean (SD)
158 45.15 (11.89)
Table 2 Clinical characteristics
Clinical characteristics n=162
Duration of UPS in years, median (interquartile range) 9 (3–16)
Classification of UPS by SCID-I
undifferentiated somatoform disorder 63
chronic pain disorder 99
Number of comorbid DSM-IV Axis I disorders
no comorbid DSM-IV Axis I disorder 95
one comorbid DSM-IV Axis I disorder 43
two comorbid DSM-IV Axis I disorders 17
three comorbid DSM-IVAxis I disorders 4
four or more comorbid DSM-IVAxis I disorders 3
Classification of comorbid DSM-IV Axis I disorder
mood disorder (in past; in lifetime) 24 (46;70)
anxiety disorder (in past; in lifetime) 47 (30;77)
substance-related disorder (in past; in lifetime) 1 (17;18)
eating disorder (in past; in lifetime) 1 (5;6)
psychotic disorder (in past; in lifetime) 0 (1;1)
other somatoform disorder (in lifetime) 26 (26)
adjustment disorder (in lifetime) 4 (4)
other disorder (in past; in lifetime) 1 (0;1)
Number of comorbid DSM-IV Axis II disorders
no comorbid DSM-IV Axis II disorder 113
one comorbid DSM-IV Axis II disorder 27
two comorbid DSM-IV Axis II disorders 10
three or more comorbid DSM-IV Axis II disorders 10
Classification of comorbid DSM-IV Axis II disorder
paranoid personality disorder 18
schizoid personality disorder 5
schizotypal personality disorder 2
anti-social personality disorder 1
borderline personality disorder 7
histrionic personality disorder 2
narcissistic personality disorder 2
avoidant personality disorder 29
dependent personality disorder 4
obsessive compulsive personality disorder 24
Psychiatric history (number of past DSM-IV axis I disorders)
no past DSM-IV Axis I disorder 94
one past DSM-IV Axis I disorder 46
two past DSM-IV Axis I disorders 17
three past DSM-IVAxis I disorders 3
four or more past DSM-IVAxis I disorders 2
Referrer
primary medical service 82
secondary medical service 51
secondary mental service 29
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small number of cases or by violating the assumptions of
hierarchical multiple regressions analysis.
Discussion
Principal findings
We explored whether psychological symptoms,
personality-disorder characteristics, psychiatric history,
and health-related quality of life in the mental domain
assessed at baseline predicted CBT outcome at the end
of CBT (immediate outcome), three months after CBT
(short-term outcome) and one year after CBT (long-
term outcome), all after control for pretreatment scores
on the outcome measure and for socio-demographic
variables. We found that these predictors in combination
with the control variables significantly predicted the im-
mediate and short-term outcome of CBT, but not the
long-term outcome.
The predictor set alone was significantly associated
only with short-term CBT outcome. At this time-point,
all predictors were significant. Psychological symptoms
had the strongest association with short-term outcome
followed by – in descending order of strength – health-
Table 3 Correlation matrix with CBT outcomes, control
variables and predictors
CBT outcome
Immediate Short-term Long-term
CBT outcome
Immediate CBT outcome 1.00
Short-term CBT outcome .60*** 1.00
Long-term CBT outcome .58*** .58*** 1.00
Control variables
Physical Component
Summary (SF-36: PCS)
-.30** -.24* -.22*
Age -.03 .05 -.15
Gender -.02 -.01 .04
Marital status .07 -.02 .06
Employment -.07 -.08 .07
Predictors
Global severity index
(SCL-90-R)
.11 .01 .10
Personality-disorder
characteristics (VKP)
-.04 -.17 -.11
Psychiatric history (SCID-I) -.01 .13 -.01
Mental Component
Summary (SF-36: MCS)
.19 .25** .11
*p≦.05, **p≦.01, ***p≦.001.
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disorder characteristics, and psychiatric history. Psycho-
logical symptoms, health-related quality of life in the
mental domain, and psychiatric history were positively
associated with short-term outcome, meaning that a bet-
ter outcome was expected if the number of psychological
symptoms had been higher at baseline, if quality of life
had been better at baseline, and if a psychiatric history
had been present at baseline. Personality-disorder char-
acteristics were negatively associated with short-term
outcome, meaning a better outcome was expected if the
number of personality-disorder characteristics had been
lower at baseline.
As the predictor set did not significantly predict out-
come at all three time points, its effects were not stable
over time. This instability makes it unsuitable for selec-
tion and allocation of patients to CBT.
Our principal findings in relation to the existing literature
The finding that effects of predictors were not stable
over time was consistent with the findings of other stud-
ies [7-21] that have investigated the association between
psychiatric comorbidity and outcome, and showed no
stability of predictors between studies or over time
within studies. However, unlike these studies [10,12,15],
our own study controlled statistically for the effects of
pretreatment score on the outcome measure and socio-
demographic variables. Even under these conditions,predictors still did not consistently predict which
patients benefited from CBT and which did not.
The possible reasons for the inconsistent findings over
studies on predictor effects might be that the study
groups were too small or the group of patients with UPS
studied was too heterogeneous. Other reasons might be
that the sets of predictors in the studies were wrongly
measured and/or chosen. Predicting CBT outcome
might be more complex, and may require a larger set of
variables than the sets of predictors which were investi-
gated in the studies. For instance, it may require a good
match between trainer and trainees, a supportive but
not over-protective partner, no deaths nearby, no mov-
ing house, and no termination of employment. It has
been estimated that factors in client-therapist relation-
ship account for 30% of treatment outcome, and factors
outside CBT for another 40% [40].
Strengths and limitations in the study
The strength of the present study was that the impact of
a predictor set on the primary outcome measure was
explored at three time points over one year after CBT
[2]. As most other studies were designed to predict
treatment outcome at only one time point after CBT
[8,13-15], they did not explore the stability of the pre-
dictor effect over time. They also used more than one
outcome measure without indicating the primary out-
come measure [8,12,15,18]. By this, other studies did not
explore the stability of predictor effects over time on the
outcome measure that was preliminary chosen as the
most important outcome of CBT.
A limitation of the study was that personality-disorder
characteristics were measured using a self-report ques-
tionnaire. Although many patients met the DSM-IV axis
II criteria for the classification of a specific personality-
disorder subtype, only two met the general criteria ap-
plying to all personality disorders. Patients seemed to
view any maladaptive thoughts, feelings and behavior
associated with personal and social disruption as a spe-
cific reaction to a situation rather than a pervasive and
stable pattern across many situations. If these reactions
were indeed determined by a specific situation, our clas-
sification of their personality disorders would have been
incorrect. However, a high number of personality disor-
ders was to be expected: our patients had had their UPS
for an average of nine years, and the prevalence of per-
sonality disorders in such patients is four times higher
than in the healthy population [41]. The total number of
DSM-IV axis II criteria confirmed in our study
(mean=15.07 and standard deviation=12.96) was signifi-
cantly larger than the mean in the ‘normal population’
reference group (mean=12.54 and standard devi-
ation=9.79), and significantly less than the one in the
‘psychiatric patients’ reference group (mean=25.37 and
Table 4 Hierarchical multiple regression models for predicting CBT outcome
Immediate CBT outcomea Short-term CBT outcomeb Long-term CBT outcomec
b Standard error βI R2 b Standard error βI R2 b Standard error βI R2
Step 1
Constant 13.10 4.10 9.09 3.72 14.88 4.38
Control variables
Physical Component
Summary (SF-36: PCS)
−0.27 0.08 -.34** −0.19 0.08 -.26* −0.22 0.08 -.27*
Age −0.05 0.07 -.07 0.03 0.07 .04 −0.11 0.08 -.16
Gender 2.33 2.02 .12 1.09 1.79 .06 2.66 2.11 .13
Marital status 1.60 1.65 .10 −0.49 1.51 -.03 1.39 1.66 .09
Employment −0.36 1.69 -.02 −0.16 1.51 -.01 1.26 1.73 .08
Explained variance by
control variables (R2)
.11 .07 .10
Step 2
Constant −10.06 10.22 −12.36 8.24 0.87 10.57
Control variables
Physical Component
Summary (SF-36: PCS)
−0.16 0.09 -.20 −0.10 0.08 -.13 −0.15 0.09 -.19
Age −0.01 0.07 -.02 0.04 0.06 .06 −0.10 0.08 -.14
Gender 1.05 2.20 .05 0.92 1.89 .05 1.51 2.32 .07
Marital status 1.85 1.65 .11 −0.42 1.42 -.03 1.25 1.66 .08
Employment −0.53 1.68 -.03 −0.71 1.43 -.05 1.06 1.73 .06
Predictors
Global severity index (SCL-90) 0.06 0.03 .36* 0.06 0.02 .41** 0.06 0.03 .33*
Personality-disorder
characteristics (VKP)
−0.08 0.09 -.11 −0.19 0.07 -.32* −0.18 0.09 -.28*
Psychiatric history (SCID) 0.72 1.50 .05 2.79 1.27 .20* 1.12 1.52 .07
Mental Component
Summary (SF-36: MCS)
0.20 0.09 .30* 0.21 0.07 .36** 0.10 0.09 .15
Explained variance by
predictors ( ΔR2)
.06 .15** .06
a Immediate CBT outcome was computed by subtracting the baseline PCS-score from the post-training PCS-score.
b Short-term CBT outcome was computed by subtracting the baseline PCS-score from the three-months follow-up PCS-score.
c Long-term CBT outcome was computed by subtracting the baseline PCS-score from the one-year follow-up PCS-score.
I β is the standardized value of b.
*p≦.05, **p≦.01, ***p≦.001.
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caused by failure to meet the general criteria applicable
to all personality disorders might be partially solved by
using structured interviews. Although this might provide
a more objective perspective, it still depends on informa-
tion communicated by patients and also on patients’
views of their own thoughts, feelings and behavior.
Clinical and policy implications
In routine practice assessments, patients with UPS are
selected and allocated to different kinds of treatment on
the basis of psychological symptoms, personality-
disorder characteristics, psychiatric history, and health-
related quality of life. As the prevalence of comorbid
mood, anxiety [42], and personality disorders [41] is high
in this patient group, patients are often redirected fromtreatment for UPS to treatment for mental health pro-
blems, which is usually provided by the mental health
services. However, these predictors did not consistently
predict CBT outcome, neither in our study nor in our
review of other studies, and as a substantial number of
patients communicates in physical and not mental terms
[43] and refuses to be referred to the mental health ser-
vices [5,44], this practice does not seem to be
appropriate.
Conclusions
As psychological symptoms, personality-disorder charac-
teristics, psychiatric history, and health-related quality of
life in the mental domain assessed at baseline did not
seem to predict CBT outcome consistently over time,
the need for selection and allocation of patients on the
Zonneveld et al. BMC Public Health 2012, 12:848 Page 9 of 10
http://www.biomedcentral.com/1471-2458/12/848basis of these variables to CBT is doubtful. In our study,
if patients had been excluded from CBT on the basis of
these variables, they would have been deprived unneces-
sarily of effective group training.
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